Physician profile
Shaun S Baker
NPI 1083909543
$3,678.35
in general payments reported to CMS, 2019-2025
18 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $420 · 2021: $325 · 2022: $854 · 2023: $187 · 2024: $1,448 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931 · Travel and Lodging: $821 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.17 |
| Travel and Lodging | $820.70 |
| Education | $133.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,227.82 | 2024 | Mazor X System, Stealthstation S8 Platform |
| Genzyme Corporation | $468.68 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $445.78 | 2019-2025 | Dupixent |
| Acclarent, INC | $316.91 | 2020-2023 | Trudi Nav Cable, Acclarent Aera |
| Intersect Ent, INC. | $316.47 | 2020-2022 | |
| Cochlear Americas | $226.48 | 2022 | |
| Stryker Corporation | $184.31 | 2020-2025 | Xpress Loprofile |
| Smith+Nephew, INC. | $125.27 | 2022 | |
| Alk-Abello, INC | $115.00 | 2020 | |
| Optinose US, INC. | $64.34 | 2019-2025 | |
| Glaxosmithkline, LLC. | $46.83 | 2022 | |
| Integra Lifesciences Corporation | $29.43 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Aerin Medical INC. | $26.66 | 2020-2022 | |
| Csl Behring | $22.51 | 2025 | Hizentra |
| Boston Scientific Corporation | $19.08 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $17.79 | 2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $13.33 | 2019 | |
| Kaleo, INC. | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaun Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.